
|Videos|October 21, 2022
Dr. He Discusses Discovery of Cancer-Inducing Mutation in Thymic Epithelial Cells
Author(s)Yongfeng He, PhD
Yongfeng He, PhD, discusses the identification of the GTF2I L424H mutation in mouse models of thymic cancer.
Advertisement
Yongfeng He, PhD, is an instructor of cancer biology in medicine at Weill Cornell Medicine in New York, New York.
He, along with Giuseppe Gianccone, MD, PhD, professor of medicine and associate director of clinical research at the Sandra and Edward Meyer Cancer Center at Weill Cornell, identified the GTF2I L424H mutation in mouse models.
Giaconne was the first to idenfiy the mutation. Together, the 2 investigators determined that this single-point mutation in thymic epithelial cells can induce thymic tumors.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
4
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
5




































